I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter @theroberthart or email me at [email protected]
it had dosed the first participant in a study designed to test its EBV vaccine in early January, and will evaluate the shot’s safety and dosage in around 270 people.
If successful, the shot, built using the same mRNA technology in the company’s Covid-19 vaccine, could be the first EBV vaccine on the market. The Moderna trial comes at the same time Harvard researchers linked infection with the common virus to MS, a neurological condition affecting someAmericans, after studying data from more than 10 million people serving in the U.S. military.
The risk of MS increased 32-fold after infection with EBV but was unchanged after infection with other viruses, the researchers found, findings that could not be explained with any other known risk factor for MS and mark “the first study providing compelling evidence of causality,”Alberto Ascherio, professor of epidemiology and nutrition at Harvard Chan School of Public Health and the study’s senior author.
Ascherio said the findings were a “big step” and suggest most cases of MS could be prevented by stopping infection with EBV, as well as opening up the possibility of a cure for MS by “targeting EBV.” EBV has been suspected of playing a role in MS for a long time but obtaining strong proof has been difficult given how many people—95% of adults worldwide—have been infected. For most this infection is harmless.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna Starts Human Trials Of mRNA Vaccine For Virus That Likely Causes Multiple SclerosisI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
As the omicron semester starts, online or in person, colleges are tenseLEXINGTON, Ky. - By 9 a.m. on the first day of the spring term, 15 or so students in the University of Kentucky's honors college had settled into their seats here for a seminar on knowledge and society. Eric Welch, their instructor, mused about how to pronounce omicron - with a short or long 'o' in the first syllable? - and lamented that he couldn't see more than half of their masked faces. He told them it would be an easy A if they show up and do the work. 'Your presence in this class matters,'
Read more »
Google starts rolling out the Pixel 6 and 6 Pro's delayed December update | EngadgetGoogle has begun rolling out the Pixel 6 and 6 Pro’s latest update following a delay in December..
Read more »
Boston's vaccine mandate for indoor dining and workouts starts SaturdayBoston's vaccine mandate for indoor dining takes effect on Saturday, and some restaurant owners are worried it will hurt their already ailing business.
Read more »
Porzingis starts fast in return, Mavs roll past Magic 108-92Kristaps Porzingis scored 12 of his 19 points in the first quarter of his first game in two weeks and the Dallas Mavericks cruised to a 108-92 victory over the Orlando Magic on Saturday night.
Read more »
The fight to stop the next pandemic starts in the jungles of BorneoGlobalization and ecological disturbances have knocked down many of the natural barriers that keep viruses at bay. Smart conservation practices can change that.
Read more »